Search results

Search market news

20 stories
tradingview

Teradyne, Inc. Stock 12‑Month Price Target Raised to $444.5, Implies 39% Upside

Explore more price target data and ratings for Teradyne, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Teradyne, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is n…

TradingView en_IN
StocksUS
tradingview

uniQure N.V. Stock 12‑Month Price Target Raised to $66.08, Implies 80% Upside

Explore more price target data and ratings for uniQure N.V. on the Forecasts tab, and track all previous and future analyst recommendations for uniQure N.V. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a…

TradingView en_IN
StocksUS
tradingview

Qorvo, Inc. Stock 12‑Month Price Target Raised to $91.2, Implies 1% Downside

Explore more price target data and ratings for Qorvo, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Qorvo, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a r…

TradingView en_IN
StocksUS
tradingview

NeoGenomics, Inc. Stock 12‑Month Price Target Raised to $19.72, Implies 47% Upside

Explore more price target data and ratings for NeoGenomics, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for NeoGenomics, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This informatio…

TradingView en_IN
StocksUS
tradingview

Biogen Inc. Stock 12‑Month Price Target Raised to $231.82, Implies 13% Upside

Explore more price target data and ratings for Biogen Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Biogen Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a r…

TradingView en_IN
StocksUS
tradingview

Axogen, Inc. Stock 12‑Month Price Target Raised to $51.33, Implies 25% Upside

Explore more price target data and ratings for Axogen, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Axogen, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a…

TradingView en_IN
StocksUS
tradingview

Nve President & CEO Sold Shares Worth Over $2.2M

Daniel A. Baker, a Director and President & CEO, reported direct sales of Nve common stock in three cashless net option exercises. The weighted average selling price across the three transactions was $114.91 per share. The total proceeds from the sales were $2,298,260. Following the reported transa…

TradingView en_IN
StocksUS